|
G |
Bcl2l1 |
Bcl2-like 1 |
affects response to substance |
ISO |
BCL2L1 protein affects the susceptibility to rucaparib |
CTD |
PMID:32927276 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
affects response to substance |
ISO |
BRCA1 protein affects the susceptibility to rucaparib |
CTD |
PMID:32927276 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brd4 |
bromodomain containing 4 |
affects response to substance |
ISO |
BRD4 protein affects the susceptibility to rucaparib |
CTD |
PMID:32927276 |
|
NCBI chr 7:11,216,446...11,296,029
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
ISO |
rucaparib results in increased expression of CASP3 protein [Irinotecan co-treated with rucaparib] results in increased expression of CASP3 protein |
CTD |
PMID:30612311 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
rucaparib inhibits the reaction [Ethanol results in increased expression of CCL2 protein] |
CTD |
PMID:29317476 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[rucaparib co-treated with Dasatinib] results in decreased expression of CCND1 protein |
CTD |
PMID:32927276 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk9 |
cyclin-dependent kinase 9 |
affects response to substance |
ISO |
CDK9 protein affects the susceptibility to rucaparib |
CTD |
PMID:32927276 |
|
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions affects expression |
ISO |
[Irinotecan co-treated with rucaparib] results in increased expression of H2AX protein; [rucaparib co-treated with CPI-0610] results in increased expression of H2AX protein; [rucaparib co-treated with Dasatinib co-treated with CPI-0610] results in increased expression of H2AX protein; [rucaparib co-treated with Dasatinib] results in increased expression of H2AX protein rucaparib affects the expression of H2AX protein |
CTD |
PMID:30612311 PMID:32927276 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
rucaparib inhibits the reaction [Ethanol results in increased expression of IL6 protein] |
CTD |
PMID:29317476 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
ISO |
[Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein |
CTD |
PMID:30612311 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions decreases expression |
ISO |
[rucaparib co-treated with Dasatinib co-treated with CPI-0610] results in increased cleavage of PARP1 protein; rucaparib binds to and results in decreased activity of PARP1 protein; rucaparib inhibits the reaction [Irinotecan results in increased expression of PARP1 protein]; rucaparib promotes the reaction [navitoclax results in increased cleavage of PARP1 protein] rucaparib results in decreased expression of PARP1 protein |
CTD |
PMID:28001384 PMID:30612311 PMID:32927276 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp2 |
poly (ADP-ribose) polymerase 2 |
decreases activity |
ISO |
rucaparib results in decreased activity of PARP2 protein |
CTD |
PMID:28001384 |
|
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
[Irinotecan co-treated with rucaparib] results in decreased expression of RPS6KB1 protein |
CTD |
PMID:30612311 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
affects response to substance increases phosphorylation multiple interactions |
ISO |
SRC protein affects the susceptibility to rucaparib rucaparib results in increased phosphorylation of SRC protein [rucaparib co-treated with Dasatinib] results in decreased phosphorylation of SRC protein |
CTD |
PMID:32927276 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
rucaparib inhibits the reaction [Ethanol results in increased expression of TNF protein] |
CTD |
PMID:29317476 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnks2 |
tankyrase 2 |
affects binding |
ISO |
rucaparib binds to TNKS2 protein |
CTD |
PMID:28001384 |
|
NCBI chr 1:234,567,888...234,621,079
Ensembl chr 1:234,567,858...234,621,079
|
|